Cite
MLA Citation
Stephen R. D. Johnston et al.. “Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.” Journal of clinical oncology, vol. 39, no. 1, 2021, pp. 79–89. http://access.bl.uk/ark:/81055/vdc_100168588999.0x00000f